Product Reports Resources Pricing Login Book a demo

Annoroad

Biotech & Life Sciences · Dongcheng District, China · Founded 2012

A leading developer and marketer on genomic innovation technologies for research and clinical market MoreLess

Annoroad is a biotechnology company headquartered in Beijing, China, that was founded in 2012 by Junbin Liang and Chongjian Chen. The company specializes in the application of next-generation sequencing (NGS) technology to provide a range of services to the research and clinical markets.

Annoroad's business model is centered on providing integrated solutions for genomics research and diagnostics. This includes a variety of sequencing services, such as single-cell sequencing, epigenetic sequencing, and transcriptome sequencing. In the clinical diagnostics space, the company has developed and offers a number of products, including non-invasive prenatal testing (NIPT), genetic testing for hereditary tumors, and testing for rare diseases. Annoroad serves a diverse client base that includes hospitals, research institutions, and pharmaceutical companies.

The company has a significant research and development focus, with a team of scientists and bioinformaticians dedicated to developing new applications for genomic technologies. Annoroad has also established a number of partnerships with academic institutions and other companies in the life sciences industry to advance its research and development efforts.

Keywords: genomics, biotechnology, next-generation sequencing, molecular diagnostics, bioinformatics, clinical diagnostics, genetic testing, research services, life sciences, sequencing services

Valuation $100–500M
Revenue $50–100M
Headcount <100
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Annoroad and the history behind them.

Company overview

Annoroad company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2012
Headquarters
Dongcheng District, China
Employees
28
Open positions
None listed
Dealroom signal
74.3
Investment activity
1 companies · latest Mar 2024
Capital deployed
$2.8M
Preferred round
EARLY VC
client focusb2btechnologyBig DatatechnologyDeep Techsub industryBioTechnologysectorAlternative Medicinebusiness modelManufacturingsectorTestingindustryHealthsectorBiotechnologysectorOncologysectorDNAsectorGenetics and genomicssectorSequencingsectorNon-Invasive medical devices and treatments

Valuation & funding

Annoroad funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOExit Mar 2025 $0 Undisclosed
SERIES CEquity / VC Nov 2017 $100M $400M SAIF Partners · SB China Capital · Ping An Ventures · ShenZhen GTJA Investment Group
SERIES BEquity / VC Apr 2015 $0 Undisclosed
SERIES AEquity / VC Dec 2013 $0 Undisclosed
ANGELEquity / VC Jun 2012 $0 Undisclosed
Showing 5 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $75M 0% 28
2025 $75M +5.6% 27
2024 $71M +9.1% 16
2023 $65M +9.2% 28
2022 $60M 26
2021 29
2020 28
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Annoroad website traffic

Latest recorded traffic for Annoroad is 160 monthly website visits, down 66% over the last three months. Annoroad's team grew 3.7% over the past year.

Latest monthly visits160 3-month web change-66% 1-year team growth+3.7%
Monthly website visits49 observations · Mar 2017–Mar 2023
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Annoroad compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Capital deployed

Annoroad investments and acquisitions

Recent portfolio relationships for companies that also act as investors or acquirers.

Talent graph

Annoroad's talent

Book a demo to see the people
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on Annoroad's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series B+ 4 investors entered at this stage
SAIF Partners
SB China Capital
Ping An Ventures
ShenZhen GTJA Investment Group

Global footprint

Where Annoroad has talent and traffic

Workforce by country
2 countries with
team presence
🇨🇳 China90%
🇫🇷 France10%
2 countries shown

In the news

Latest news about Annoroad

Recent press, funding announcements, and product moves mentioning Annoroad — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Annoroad

An AI-synthesized read of the highest-engagement posts about Annoroad on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Annoroad’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.